Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Search in:

Advanced search

Journal of Medical Economics Volume 24, 2021 - Issue 1

Submit an article Journal homepage

Open access

2,820

Views

CrossRef citations to date

Altmetric

Oncology

The cost-effectiveness of glasdegib in combination with low-dose cytarabine, for the treatment of newly diagnosed acute myeloid leukemia in adult patients who are not eligible to receive intensive induction chemotherapy in Canada

Yannan Hua Ingress-Health, Rotterdam, the NetherlandsCorrespondence[email protected]

Majed Charaanb Pfizer Canada Inc, Quebec, Canada

Ilse van Oostruma Ingress-Health, Rotterdam, the Netherlands

Bart Heega Ingress-Health, Rotterdam, the Netherlands

https://orcid.org/0000-0002-9226-3232

Timothy Bellc Pfizer Inc, New York, USA

Pages 150-161 | Received 23 Oct 2020, Accepted 21 Dec 2020, Published online: 01 Feb 2021

Cite this article
https://doi.org/10.1080/13696998.2021.1875743
CrossMark

Full Article
Figures & data
References
Supplemental
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Lan Gao, Dieu Nguyen & Peter Lee. (2022) A systematic review of economic evaluations for the pharmaceutical treatment of chronic lymphocytic leukemia and acute myeloid leukemia. Expert Review of Hematology 15:9, pages 833-847.
Read now

Monia Marchetti, Luca Albertin, Giulia Limberti & Manuela Canicattì. (2022) Pharmacoeconomic considerations for acute myeloid leukemia pharmacotherapy. Expert Opinion on Pharmacotherapy 23:2, pages 263-272.
Read now

Articles from other publishers (1)

Charles A. Schiffer. (2023) Glasdigib fails to slay the hedgehog in pivotal AML trials. Leukemia 37:12, pages 2520-2521.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references